ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Cullinan Therapeutics Inc

Cullinan Therapeutics Inc (CGEM)

12,68
0,29
(2,34%)
Geschlossen 06 Januar 10:00PM
12,68
-0,019
(-0,15%)
Nach Börsenschluss: 10:04PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
12,68
Gebot
12,50
Fragen
13,55
Volumen
290.627
12,515 Tagesbereich 12,985
9,95 52-Wochen-Bereich 30,1886
Marktkapitalisierung
Handelsende
12,39
Handelsbeginn
12,565
Letzte Trade
1
@
12.68
Letzter Handelszeitpunkt
Finanzvolumen
US$ 3.699.715
VWAP
12,7301
Durchschnittliches Volumen (3 Mio.)
526.586
Ausgegebene Aktien
58.227.593
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,83
Gewinn pro Aktie (EPS)
-2,63
Erlöse
-
Nettogewinn
-153,16M

Über Cullinan Therapeutics Inc

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Cullinan Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGEM. The last closing price for Cullinan Therapeutics was US$12,39. Over the last year, Cullinan Therapeutics shares have traded in a share price range of US$ 9,95 to US$ 30,1886.

Cullinan Therapeutics currently has 58.227.593 shares in issue. The market capitalisation of Cullinan Therapeutics is US$721,44 million. Cullinan Therapeutics has a price to earnings ratio (PE ratio) of -4.83.

CGEM Neueste Nachrichten

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.2-1.5527950310612.8812.9511.7580938412.11692463CS
40.161.2779552715712.5213.610.4454503911.99233032CS
12-3.21-20.201384518615.8917.97510.4452658613.88794604CS
26-3.78-22.96476306216.4621.0110.4458692316.18424043CS
522.0919.735599622310.5930.18869.9563420418.21256416CS
156-3.02-19.235668789815.730.18867.337842515.11624258CS
260-29.32-69.80952380954259.857.335071317.82503229CS

CGEM - Frequently Asked Questions (FAQ)

What is the current Cullinan Therapeutics share price?
The current share price of Cullinan Therapeutics is US$ 12,68
How many Cullinan Therapeutics shares are in issue?
Cullinan Therapeutics has 58.227.593 shares in issue
What is the market cap of Cullinan Therapeutics?
The market capitalisation of Cullinan Therapeutics is USD 721,44M
What is the 1 year trading range for Cullinan Therapeutics share price?
Cullinan Therapeutics has traded in the range of US$ 9,95 to US$ 30,1886 during the past year
What is the PE ratio of Cullinan Therapeutics?
The price to earnings ratio of Cullinan Therapeutics is -4,83
What is the reporting currency for Cullinan Therapeutics?
Cullinan Therapeutics reports financial results in USD
What is the latest annual profit for Cullinan Therapeutics?
The latest annual profit of Cullinan Therapeutics is USD -153,16M
What is the registered address of Cullinan Therapeutics?
The registered address for Cullinan Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Cullinan Therapeutics website address?
The website address for Cullinan Therapeutics is www.cullinantherapeutics.com
Which industry sector does Cullinan Therapeutics operate in?
Cullinan Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
350,92M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
330,82M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,59M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
259,78M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
222,72M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock